デフォルト表紙
市場調査レポート
商品コード
1576954

外科用ドレナージデバイスの世界市場:洞察、競合情勢、市場予測:2030年

Surgical Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
外科用ドレナージデバイスの世界市場:洞察、競合情勢、市場予測:2030年
出版日: 2024年10月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

外科用ドレナージデバイスの市場規模は、2023年に18億5,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に5.67%のCAGRで拡大し、2030年には25億7,000万米ドルに達すると予測されています。外科用ドレナージデバイス市場は、がんや前立腺肥大症(BPH)などの慢性疾患の有病率の上昇、肥満につながる座りがちなライフスタイルによる外科手術の増加、低侵襲外科手術への嗜好の高まりにより急速に拡大しており、2024年から2030年までの予測期間中に外科用ドレナージデバイス市場全体の成長をエスカレートさせると予測されます。

また、2024年に世界保健機関(WHO)が提供したデータでは、国際がん研究機関(IARC)は、2022年に世界で2,000万件のがんが新たに登録されたと述べています。さらに、同じ情報源によると、登録された新規のがん症例のうち、肺がんは世界で250万件の新規症例を占め、最も一般的ながんとなっています。がん手術の増加に伴い、効率的な体液管理は合併症を予防し回復を促進するために不可欠であり、がん治療プロトコルにこれらの装置が不可欠となっています。この動向は、患者の安全性と最適な治癒を確保する上で外科用ドレナージデバイスの重要性が高まっていることを浮き彫りにしており、それゆえがん患者の増加が外科用ドレナージデバイス市場の需要を牽引しています。

世界保健機関(WHO)が提供したデータ(2024年)によると、2022年には世界全体で8人中1人が肥満と共存していました。さらに、同じ資料によると、2022年には約25億人が太りすぎで、このうち8億9千万人が世界中で肥満とともに生活していました。肥満とそれに関連する合併症の有病率が世界的に上昇し続けているため、重度の肥満に対する効果的な治療法として肥満手術の需要が高まっています。このような肥満手術の需要の増加は、これらの手術で使用される外科用ドレナージデバイスの需要の増加に直結します。

したがって、上記の要因が総合的に外科用ドレナージデバイス市場全体の成長を牽引することになります。

しかし、外科用ドレナージデバイスの使用に伴うリスク、代替手技の利用可能性などが、外科用ドレナージデバイス市場の成長にとって課題であることが判明する可能性があります。

当レポートでは、世界の外科用ドレナージデバイス市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 外科用ドレナージデバイス市場レポートのイントロダクション

第2章 外科用ドレナージデバイス市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 外科用ドレナージデバイス市場の主な要因分析

  • 外科用ドレナージデバイスの市場促進要因
  • 外科用ドレナージデバイスの市場抑制要因と課題
  • 外科用ドレナージデバイスの市場機会

第6章 外科用ドレナージデバイス市場におけるポーターのファイブフォース分析

第7章 外科用ドレナージデバイスの市場評価

  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第8章 外科用ドレナージデバイス市場の企業と製品プロファイル

  • Medtronic
  • Cardinal Health Inc.
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Cook Medical
  • Acelity I.P Inc.
  • BD
  • Johnson & Johnson Services, Inc
  • Medela AG
  • ConvaTec Group Plc.
  • Romsons Group Private Ltd.
  • Redax S.P.A
  • Medline Industries Inc.
  • Integra LifeSciences
  • Poly Medicure
  • Global Medikit
  • Degania Silicone
  • Stryker
  • Teleflex Incorporated
  • Smith & Nephew plc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Surgical drainage devices Market in Global (2021-2030)
  • Table 3: Surgical drainage devices Market in Global by Type (2021-2030)
  • Table 4: Surgical drainage devices Market in Global by Application (2021-2030)
  • Table 5: Surgical drainage devices Market in Global by End-User (2021-2030)
  • Table 6: Surgical drainage devices Market in Global by Geography (2021-2030)
  • Table 7: Surgical drainage devices Market in North America (2021-2030)
  • Table 8: Surgical drainage devices Market in the United States (2021-2030)
  • Table 9: Surgical drainage devices Market in Canada (2021-2030)
  • Table 10: Surgical drainage devices Market in Mexico (2021-2030)
  • Table 11: Surgical drainage devices Market in Europe (2021-2030)
  • Table 12: Surgical drainage devices Market in France (2021-2030)
  • Table 13: Surgical drainage devices Market in Germany (2021-2030)
  • Table 14: Surgical drainage devices Market in United Kingdom (2021-2030)
  • Table 15: Surgical drainage devices Market in Italy (2021-2030)
  • Table 16: Surgical drainage devices Market in Spain (2021-2030)
  • Table 17: Surgical drainage devices Market in the Rest of Europe (2021-2030)
  • Table 18: Surgical drainage devices Market in Asia-Pacific (2021-2030)
  • Table 19: Surgical drainage devices Market in China (2021-2030)
  • Table 20: Surgical drainage devices Market in Japan (2021-2030)
  • Table 21: Surgical drainage devices Market in India (2021-2030)
  • Table 22: Surgical drainage devices Market in Australia (2021-2030)
  • Table 23: Surgical drainage devices Market in South Korea (2021-2030)
  • Table 24: Surgical drainage devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Surgical drainage devices Market in the Rest of the World (2021-2030)
  • Table 26: Surgical drainage devices Market in the Middle East (2021-2030)
  • Table 27: Surgical drainage devices Market in Africa (2021-2030)
  • Table 28: Surgical drainage devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Surgical drainage devices Market in Global (2021-2030)
  • Figure 3: Surgical drainage devices Market in Global by Type (2021-2030)
  • Figure 4: Surgical drainage devices Market in Global by Application (2021-2030)
  • Figure 5: Surgical drainage devices Market in Global by End-User (2021-2030)
  • Figure 6: Surgical drainage devices Market in Global by Geography (2021-2030)
  • Figure 7: Surgical drainage devices Market in North America (2021-2030)
  • Figure 8: Surgical drainage devices Market in the United States (2021-2030)
  • Figure 9: Surgical drainage devices Market in Canada (2021-2030)
  • Figure 10: Surgical drainage devices Market in Mexico (2021-2030)
  • Figure 11: Surgical drainage devices Market in Europe (2021-2030)
  • Figure 12: Surgical drainage devices Market in France (2021-2030)
  • Figure 13: Surgical drainage devices Market in Germany (2021-2030)
  • Figure 14: Surgical drainage devices Market in United Kingdom (2021-2030)
  • Figure 15: Surgical drainage devices Market in Italy (2021-2030)
  • Figure 16: Surgical drainage devices Market in Spain (2021-2030)
  • Figure 17: Surgical drainage devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Surgical drainage devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Surgical drainage devices Market in China (2021-2030)
  • Figure 20: Surgical drainage devices Market in Japan (2021-2030)
  • Figure 21: Surgical drainage devices Market in India (2021-2030)
  • Figure 22: Surgical drainage devices Market in Australia (2021-2030)
  • Figure 23: Surgical drainage devices Market in South Korea (2021-2030)
  • Figure 24: Surgical drainage devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Surgical drainage devices Market in the Rest of the World (2021-2030)
  • Figure 26: Surgical drainage devices Market in the Middle East (2021-2030)
  • Figure 27: Surgical drainage devices Market in Africa (2021-2030)
  • Figure 28: Surgical drainage devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0597

Surgical Drainage Devices market by Type (Active [Jackson-Pratt Drains, Hemovac Drains, Blake Drains, Negative Pressure Wound Therapy, and Others], Passive [Penrose Drains and Others]), Application (General Surgery, Cardiovascular and Thoracic Surgery, Obstetric/Gynecological Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of chronic disorders and growing number of surgical procedures worldwide

The surgical drainage devices market was valued at USD 1.85 billion in 2023 and is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 2.57 billion by 2030. The Surgical drainage devices market is expanding rapidly due to the increasing prevalence of chronic disorders such as cancers and benign prostatic hyperplasia (BPH), the growing number of surgical procedures due to a sedentary lifestyle leading to obesity, and the increasing preference for minimally invasive surgical procedures that are expected to escalate the overall growth of the surgical drainage devices market during the forecast period from 2024 to 2030.

Surgical drainage devices Market Dynamics:

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

Also, data provided by the World Health Organization (WHO) in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. As cancer surgeries rise, efficient fluid management is essential to prevent complications and enhance recovery, making these devices indispensable in cancer treatment protocols. This trend highlights their growing importance in ensuring patient safety and optimal healing and hence rising cancer cases are driving demand for surgical drainage devices market.

Data from the National Institute of Health (2024) stated that the current prevalence of benign prostatic hyperplasia (BPH) is 50% to 60% for people in their 60s, increasing to 80% to 90% of those older than 70 years of age, globally. Moreover, the World Health Organization (2021) further stated that between 2015 and 2050, people between 60 years and above will double from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. As BPH leads to urinary retention, interventions such as catheterization and minimally invasive procedures often require drainage systems to manage fluids and reduce post-operative complications, particularly in older patients. This growing demographic is fueling the need for efficient drainage solutions in urological care.

According to the data provided by the World Health Organization (2024), in 2022 globally out of 8 people, 1 person was living with obesity. Furthermore, as per the same source in 2022, approximately 2.5 billion people were overweight and out of these 890 million people were living with obesity worldwide. As the prevalence of obesity and related comorbidities continues to rise globally, there is a growing demand for bariatric surgery as an effective treatment option for severe obesity. This increased demand for bariatric procedures directly translates to a higher demand for surgical drainage devices used in these surgeries.

Therefore, the factors stated above collectively will drive the overall surgical drainage devices market growth.

However, risks associated with the use of surgical drainage devices, availability of alternative procedures, and others may prove to be challenging factors for surgical drainage devices market growth.

Surgical drainage devices Market Segment Analysis:

Surgical Drainage Devices market by Type (Active [Jackson-Pratt Drains, Hemovac Drains, Blake Drains, Negative Pressure Wound Therapy, and Others], Passive [Penrose Drains and Others]), Application (General Surgery, Cardiovascular and Thoracic Surgery, Obstetric/Gynecological Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the surgical drainage devices market, the negative pressure wound therapy, sub-category of active surgical drainage devices is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and features of negative pressure wound therapy that enhance their utility and effectiveness.

One of the benefits is their convenience and ease of use, as these devices come pre-assembled and ready for immediate application, eliminating the need for complex setup and maintenance.

This streamlined approach reduces the risk of infection and simplifies the treatment process for healthcare providers. Additionally, negative pressure wound therapy devices are designed to be compact and portable, making them ideal for use in a variety of settings, including outpatient clinics and home care environments. Their disposable nature also minimizes the risk of cross-contamination and eliminates the need for time-consuming cleaning and reprocessing.

Moreover, new developments in the negative pressure wound therapy product lines and new product launches are bolstering the sub-category growth. For instance, in January 2022, Smith & Nephew plc added new indications for its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker's systems for reducing the incidence of both deep and superficial incisional surgical sites and dehiscence. The Pico 7Y system, which treated two wounds simultaneously, was also cleared to aid in the reduction of the incidence of superficial incisional SSIs for high-risk patients in class I wounds, post-operative seroma, and dehiscence.

Therefore the widespread uses and various features of negative pressure wound therapy enhance performance and usability, solidifying the significant impact on the growth of the overall surgical drainage devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall surgical drainage devices market:

Among all the regions, North America is expected to dominate the surgical drainage devices market in the year 2023 and is expected to do the same during the forecast period. This is driven by the increasing number of orthopedic surgeries along with rising aesthetic procedures in the region. Advancement in surgical drainage devices, regulatory support, and the introduction of innovative devices by key market players are acting as key factors contributing to the growth of the surgical drainage devices market in the North America region during the forecast period from 2024 to 2030.

According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries were performed annually in the U.S, encompassing total shoulder replacement, hemi arthroplasty, and reverse total shoulder replacement. As per the same source, it projects that by 2025, the number of shoulder replacement procedures in the U.S. could range between 174,000 and 350,000.

As per data by the International Society of Aesthetic Plastic Surgery (2023), the total number of aesthetic procedures that took place in the US were 6,196,701, including both surgical and non-surgical procedures. The US was also the country with the highest number of non-surgical procedures worldwide in 2023, with 4,405,599 procedures in 2023. The source further stated that the US was the country with the highest number of aesthetic surgeons globally, with 7,750 surgeons in 2023.

Since number of orthopedic and aesthetic surgeries are increasing, surgical drainage devices are essential in preventing complications such as infections and ensuring quicker recovery. As surgical complexity increases, advanced drainage systems become critical in improving patient outcomes and reducing hospital stays. Thereby escalating the market for surgical drainage devices.

Rising product developmental activities by regulatory bodies and key players in the region will further boost the market for surgical drainage devices. For example, in August 2021, OMAVAC Medical Solutions, Inc. announced the grant of a United States Patent, covering its SOMAVAC SVS Smart Suction Technology and surgical drain management platform.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American surgical drainage devices market.

Surgical drainage devices Market key players:

Some of the key market players operating in the surgical drainage devices market include Medtronic, Cardinal Health Inc., Zimmer Biomet, B. Braun Melsungen AG, Cook Medical, Acelity I.P Inc., BD, Johnson & Johnson Services, Inc, Medela AG, ConvaTec Group Plc., Romsons Group Private Ltd., Redax S.P.A, Medline Industries Inc., Integra LifeSciences, Poly Medicure, Global Medikit, Degania Silicone, Stryker, Teleflex Incorporated, Smith & Nephew plc., and others.

Recent Developmental Activities in the surgical drainage devices Market:

  • In April 2022, Bearpac Medical and APR Medtech signed an exclusive distribution agreement for the sale of the Passio Pump Drainage System.
  • In August 2021, OMAVAC Medical Solutions, Inc. announced the granting of a United States Patent, covering its SOMAVAC SVS Smart Suction Technology and surgical drain management platform.

Key Takeaways from the surgical drainage devices Market Report Study

  • Market size analysis for current surgical drainage devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the surgical drainage devices market.
  • Various opportunities available for the other competitors in the surgical drainage devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current surgical drainage devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for surgical drainage devices market growth in the coming future?

Target Audience who can be benefited from this surgical drainage devices Market Report Study

  • Surgical drainage devices product providers
  • Research organizations and consulting companies
  • Surgical drainage devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Surgical drainage devices
  • Various end-users who want to know more about the surgical drainage devices market and the latest technological developments in the Surgical drainage devices market

Frequently Asked Questions for the surgical drainage devices Market:

1. What are surgical drainage devices?

  • The surgical drainage devices are tubes used in post-operative patient care, that are positioned close to surgical wounds to remove pus, blood, or other fluids and stop it from building up in the body. Surgical drains enable the drainage of liquid and/or gas from a wound or bodily cavity.

2. What is the market for surgical drainage devices?

  • The surgical drainage devices market was valued at USD 1.85 billion in 2023 and is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 2.57 billion by 2030.

3. What are the drivers for the surgical drainage devices market?

  • The Surgical drainage devices market is expanding rapidly due to the increasing prevalence of chronic disorders such as cancers and benign prostatic hyperplasia (BPH), the growing number of surgical procedures due to a sedentary lifestyle leading to obesity, and the increasing preference for minimally invasive surgical procedures that are expected to escalate the overall growth of the surgical drainage devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the surgical drainage devices market?

  • Some of the key market players operating in surgical drainage devices include Medtronic, Cardinal Health Inc., Zimmer Biomet, B. Braun Melsungen AG, Cook Medical, Acelity I.P Inc., BD, Johnson & Johnson Services, Inc, Medela AG, ConvaTec Group Plc., Romsons Group Private Ltd., Redax S.P.A, Medline Industries Inc., Integra LifeSciences, Poly Medicure, Global Medikit, Degania Silicone, Stryker, Teleflex Incorporated, Smith & Nephew plc., and others.

5. Which region has the highest share in the surgical drainage devices market?

  • Among all the regions, North America is expected to dominate the surgical drainage devices market in the year 2023 and is expected to do the same during the forecast period. This is driven by the increasing number of orthopedic surgeries along with rising aesthetic procedures in the region. Advancement in surgical drainage devices, regulatory support, and the introduction of innovative devices by key market players are acting as key factors contributing to the growth of the surgical drainage devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Surgical drainage devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Surgical drainage devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Surgical drainage devices Market Key Factors Analysis

  • 5.1. Surgical drainage devices Market Drivers
    • 5.1.1. Increasing prevalence of chronic disorders
    • 5.1.2. Increasing product developmental activities
    • 5.1.3. Growing number of surgical procedures
    • 5.1.4. Rising preference for minimally invasive devices
  • 5.2. Surgical drainage devices Market Restraints and Challenges
    • 5.2.1. Risks associated with the use of surgical drainage devices
    • 5.2.2. Availability of alternative procedures
  • 5.3. Surgical drainage devices Market Opportunities
    • 5.3.1. Development of smaller and more sophisticated drainage devices

6. Surgical drainage devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Surgical drainage devices Market Assessment

  • 7.1. By Type
    • 7.1.1. Active
      • 7.1.1.1. Jackson-Pratt Drains
      • 7.1.1.2. Hemovac Drains
      • 7.1.1.3. Blake Drains
      • 7.1.1.4. Negative Pressure Wound Therapy
      • 7.1.1.5. Others
    • 7.1.2. Passive
      • 7.1.2.1. Penrose Drains
      • 7.1.2.2. Others
  • 7.2. By Application
    • 7.2.1. General Surgery
    • 7.2.2. Cardiovascular and Thoracic Surgery
    • 7.2.3. Obstetric/Gynecological Surgery
    • 7.2.4. Orthopedic Surgery
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgery Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.3. India Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Surgical drainage devices Market Size in USD million (2021-2030)

8. Surgical drainage devices Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Cardinal Health Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Zimmer Biomet
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. B. Braun Melsungen AG
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cook Medical
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Acelity I.P Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Johnson & Johnson Services, Inc
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Medela AG
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ConvaTec Group Plc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Romsons Group Private Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Redax S.P.A
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Medline Industries Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Integra LifeSciences
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Poly Medicure
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Global Medikit
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Degania Silicone
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Stryker
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Teleflex Incorporated
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Smith & Nephew plc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us